Yeovil District Hospital NHS Foundation Trust runs Yeovil District Hospital in Yeovil, Somerset, England. It provides acute care for a population of about 180,000, people living in South Somerset, North and West Dorset, and parts of Mendip.

During the past decade, Yeovil District Hospital; Macmillan Cancer Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yeovil District Hospital; Macmillan Cancer Unit" are "Breast Cancer" (3 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Yeovil District Hospital; Macmillan Cancer Unit" in a lesser frequency.

Most popular intervention types in "Yeovil District Hospital; Macmillan Cancer Unit" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab Emtansine" (2 trials), "5-Fluorouracil" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yeovil District Hospital; Macmillan Cancer Unit" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Yeovil District Hospital; Macmillan Cancer Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Yeovil District Hospital; Macmillan Cancer Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yeovil District Hospital; Macmillan Cancer Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".